Sarcopenic obesity in predialysis chronic kidney disease: Muscle strength is a predictor of mortlity and disease progression in a six-year prospective cohort.

ABSTRACT:

Introduction

Sarcopenic obesity (SO) is a poorly defined physiological condition that is associated with increased morbimortality in the general population. The prevalence of SO has increased, making it an important public health issue; however, its effects when associated with other chronic conditions are still unclear. Therefore, it is necessary to comprehend the potential outcomes in chronic kidney disease (CKD) patients.

Objective

To assess the associations of predialysis CKD patients with SO and its components with death and disease progression to renal replacement therapy (RRT).

Methods

Prospective six-year cohort with 100 patients with predialysis CKD (stages one through five). Participants were older than 18 years and signed an informed consent form. The data

SUBMITTER: Oliveira D 

PROVIDER: S-EPMC11918380 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature